Biotechnology Industry

Biotechnology industry analysis: EL7 Score and the best stocks ranked by value, profitability, and momentum.

EL7 Score

44Weak

127 of 151

P/E 15.6 vs period average 9.9 Richer than its history

Total stocks609

Total Market Cap$1.3T

Median P/E15.6x

Median Net Margin-155.6%

Value

Growth

Best Stocks in Biotechnology

Ranked among 221 stocks with a market cap above $500M. Smaller companies are excluded from the ranking.

Rank	Company	Price	Change	P/E	Fwd P/E	Value	Growth	Quality	Safety	Capital Return	EL7 Score
1/221	LKFTLakefront	$26.81	+0.0%	2.6	—	91	98	98	100	71	99
2/221	RIGLRigel Pharmaceuticals	$47.24	-0.1%	2.8	12.1	94	68	98	87	83	99
3/221	PTGXProtagonist	$148.18	+2.1%	—	100.8	33	94	89	99	41	98
4/221	INCYIncyte	$121.47	-1.5%	15.1	17.1	85	69	92	95	44	98
5/221	HRMYHarmony Biosciences	$41.52	+1.0%	13.4	9.9	93	59	85	86	78	98
6/221	EXELExelixis	$56.12	-2.3%	17.3	15.1	80	69	97	88	38	97
7/221	UTHRUnited Therapeutics	$497.11	-1.3%	17.8	16.4	79	48	82	95	100	96
8/221	AUPHAurinia	$16.10	-0.1%	7.1	14.0	86	76	83	92	68	96
9/221	NBIXNeurocrine Biosciences	$156.22	-0.2%	22.9	16.4	77	78	95	91	40	96
10/221	SRPTSarepta Therapeutics	$20.45	-0.3%	—	21.1	87	31	97	67	91	95

Page 1 of 10

Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.

ETFs with exposure to this sector

Funds that track the sector and each fund's exposure to it.

Fund	Exposure	Assets	Expense	Holdings
IBBiShares Biotechnology ETF	100.0%	$10B	0.44%	244
VHTVanguard Health Care ETF	100.0%	$21B	0.09%	411
IHIiShares U.S. Medical Devices ETF	99.7%	$3B	0.37%	46
XLVState Street Health Care Select Sector SPDR ETF	99.2%	$43B	0.08%	60

The percentage is the sector's share of the fund's assets, per the latest available data.